Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings Categories: pharmacology Posted on June 2, 2024
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis Categories: high-impact pharmacology Posted on May 20, 2024
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes Categories: pharmacology Posted on May 19, 2024
Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban Categories: high-impact pharmacology Posted on April 15, 2024
Empagliflozin after Acute Myocardial Infarction Categories: high-impact pharmacology Posted on April 8, 2024
Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial Categories: pharmacology Posted on April 6, 2024
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure Categories: high-impact pharmacology Posted on April 3, 2024
Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study Categories: pharmacology Posted on March 29, 2024
Efficacy of Angiotensin Receptor-Neprilysin Inhibitor and Its Renal Outcome in Heart Failure Patients: A Systematic Review of Randomized Clinical Trials Categories: pharmacology Posted on March 22, 2024
Effect of Dobutamine on Patients with Septic Shock: A Retrospective Nationwide Study Categories: pharmacology Posted on March 20, 2024
Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo-controlled trial Categories: pharmacology research Posted on March 4, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study Categories: pharmacology Posted on March 1, 2024
Nephrotoxic Risk Associated With Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients With Chronic Kidney Disease Categories: pharmacology Posted on February 28, 2024
Effectiveness and safety of early treatment with spironolactone for new-onset acute heart failure Categories: high-impact pharmacology Posted on February 28, 2024
Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials Categories: meta-analysis pharmacology research Posted on February 25, 2024
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning Categories: pharmacology Posted on February 24, 2024
Efficacy and safety of dorzagliatin, a novel glucokinase activators, in the treatment of T2DM: A meta-analysis of randomized controlled trials Categories: meta-analysis pharmacology research Posted on February 23, 2024
Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure Categories: pharmacology Posted on February 23, 2024
Vonoprazan: A Review in Helicobacter pylori Infection Categories: pharmacology review Posted on February 22, 2024
Things We Do for No Reason™: Furosemide-albumin coadministration for diuretic resistance Categories: high-impact pharmacology Posted on February 19, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract Infection Categories: pharmacology Posted on February 14, 2024
Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients Categories: pharmacology Posted on February 6, 2024
Things We Do for No ReasonTM : Dose adjusting apixaban in acute kidney injury Categories: high-impact pharmacology Posted on January 31, 2024
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension Categories: high-impact pharmacology research Posted on January 24, 2024
Impact of Limiting Vancomycin Loading Doses in Patients With Methicillin-resistant Staphylococcus aureus Infections After Hospital Protocol Revision Categories: pharmacology Posted on January 15, 2024
Effects of sodium-glucose co-transporter 2 inhibitors on heart failure events in chronic kidney disease: a systematic review and meta-analysis Categories: pharmacology Posted on January 13, 2024
Sodium-glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome with Diabetes Mellitus Categories: pharmacology Posted on January 12, 2024
Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials Categories: pharmacology Posted on January 12, 2024
Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis Categories: pharmacology Posted on January 11, 2024
The impact of early in-hospital use of PCSK9 inhibitors on cardiovascular outcomes in acute coronary syndrome patients: A systematic review and meta-analysis Categories: meta-analysis pharmacology Posted on January 11, 2024
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial Categories: pharmacology Posted on January 11, 2024
Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis Categories: pharmacology Posted on January 11, 2024
Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): a systematic review and meta-analysis Categories: pharmacology Posted on January 6, 2024
Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure Categories: pharmacology Posted on January 6, 2024
Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials Categories: pharmacology Posted on January 5, 2024
A comparison of clinical outcomes associated with dosing metronidazole every 8?hours versus every 12?hours: a systematic review and metaanalysis Categories: pharmacology Posted on January 4, 2024
Rates of diabetic ketoacidosis with empagliflozin use during hospitalization for acute heart failure Categories: pharmacology Posted on January 3, 2024
Safety and Efficacy of Reduced-Dose Versus Full-Dose Alteplase for Acute Pulmonary Embolism: A Multicenter Observational Comparative Effectiveness Study Categories: pharmacology Posted on January 2, 2024
SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know Categories: pharmacology Posted on December 29, 2023
Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke Categories: pharmacology Posted on December 29, 2023
Association of vancomycin-induced acute kidney injury with trough versus AUC monitoring in patients receiving extended durations of therapy Categories: pharmacology Posted on December 29, 2023
Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review Categories: pharmacology Posted on December 27, 2023
Efficacy and Safety of Apixaban Compared to Warfarin for Nonvalvular Atrial Fibrillation in End-Stage Renal Disease on Hemodialysis Categories: pharmacology Posted on December 27, 2023
Fixed-Dose Phenobarbital Versus As-Needed Benzodiazepines for the Management of Alcohol Withdrawal in Acute Care General Internal Medicine Categories: pharmacology Posted on December 27, 2023
Vericiguat treatment of heart failure: A systematic review and meta-analysis Categories: pharmacology Posted on December 22, 2023
The Impact of Midodrine On Guideline-Directed Medical Therapy in Patients Admitted with Systolic Heart Failure Categories: pharmacology Posted on December 21, 2023
Intravenous albumin utilization audit at a large community hospital Categories: pharmacology Posted on December 11, 2023
Clinical effect of high-flow nasal cannula oxygen therapy combined with naloxone on severe respiratory failure in older adult patients: a randomized controlled trial Categories: pharmacology Posted on December 11, 2023
Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia Categories: pharmacology Posted on December 11, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study Categories: pharmacology Posted on December 10, 2023
Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease Categories: pharmacology Posted on December 6, 2023
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial Categories: pharmacology Posted on December 5, 2023
Patient Perspectives on Pharmacotherapy of Alcohol Dependence Categories: pharmacology Posted on December 5, 2023
Corticosteroids for preventing postherpetic neuralgia Categories: pharmacology Posted on December 5, 2023
High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial Categories: pharmacology Posted on December 5, 2023
Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists Categories: pharmacology Posted on November 30, 2023
The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis Categories: pharmacology Posted on November 29, 2023
Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure Categories: pharmacology Posted on November 27, 2023
The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Categories: pharmacology Posted on November 21, 2023
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials Categories: pharmacology Posted on November 21, 2023
Clinical value of glucocorticoids for severe community-acquired pneumonia: A systematic review and meta-analysis based on randomized controlled trials Categories: pharmacology Posted on November 21, 2023
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies Categories: pharmacology Posted on November 20, 2023
Establishing the Safety of Phenobarbital Treatment of Alcohol Withdrawal Syndrome on General Medical Wards: A Retrospective Cohort Study Categories: pharmacology Posted on November 18, 2023
Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis Categories: pharmacology Posted on November 17, 2023
Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission Categories: pharmacology Posted on November 16, 2023
Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial Categories: pharmacology Posted on November 13, 2023
SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review Categories: pharmacology review Posted on November 11, 2023
Evaluation of Inpatient Sodium-Glucose Co-Transporter-2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure Categories: pharmacology Posted on November 9, 2023
Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections Categories: pharmacology Posted on November 8, 2023
Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI Categories: pharmacology Posted on November 7, 2023
Evaluation of the Safety and Efficacy of Metformin Use in Hospitalized, Non-Critically Ill Patients Categories: pharmacology Posted on November 6, 2023
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation in the United States Categories: pharmacology Posted on November 6, 2023
Phenobarbital Treatment of Alcohol Withdrawal in the Emergency Department: A Systematic Review and Meta-analysis Categories: pharmacology Posted on November 3, 2023
Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia Categories: pharmacology Posted on November 1, 2023
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole Categories: pharmacology Posted on October 26, 2023
Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients Categories: pharmacology Posted on October 26, 2023
Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients Categories: pharmacology Posted on October 26, 2023
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial Categories: pharmacology Posted on October 25, 2023
Anticoagulation in atrial fibrillation. A large real-world update Categories: pharmacology Posted on October 25, 2023
Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials Categories: meta-analysis pharmacology research Posted on October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials Categories: pharmacology Posted on October 25, 2023
Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients Categories: meta-analysis pharmacology Posted on October 25, 2023
Hospital-based opioid treatment: Expanding and sustaining the model in Texas Categories: pharmacology Posted on October 25, 2023
Early Initiation of PCSK9 Inhibitor Therapy versus Placebo in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis Categories: pharmacology Posted on October 24, 2023
Clinical Outcomes of Rifampicin Combination Therapy in Implant-Associated Infections due to Staphylococci and Streptococci: A Systematic Review and Meta-analyses Categories: pharmacology Posted on October 24, 2023
Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study Categories: pharmacology Posted on October 23, 2023
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials Categories: pharmacology Posted on October 23, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials Categories: pharmacology Posted on October 23, 2023
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial Categories: pharmacology Posted on October 20, 2023
Intravenous high-dose vitamin C monotherapy for sepsis and septic shock: A meta-analysis of randomized controlled trials Categories: pharmacology Posted on October 20, 2023
Anticoagulation Bridging in Patients With Left Ventricular Assist Device: A Regional Analysis of HeartMate 3 Recipients Categories: pharmacology Posted on October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Categories: pharmacology Posted on October 20, 2023
A Randomized, Controlled Trial of Prulifloxacin as Conversion Therapy after Intravenous Carbapenem in the Treatment of Acute Pyelonephritis Caused by Third Generation Cephalosporin Resistant Pathogens: A Pilot Study Categories: pharmacology Posted on October 19, 2023
Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes Categories: pharmacology Posted on October 18, 2023
Acute heart failure: current pharmacological treatment and perspectives Categories: pharmacology Posted on October 18, 2023
Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial Categories: pharmacology Posted on October 18, 2023October 30, 2023
Effectiveness and safety of non-vitamin K oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke: A systematic review and meta-analysis Categories: pharmacology Posted on October 17, 2023
Multiple Myeloma and the Role of Bisphosphonates in Its Management Categories: pharmacology Posted on October 17, 2023
Safety outcomes of salbutamol: A systematic review and meta-analysis Categories: pharmacology Posted on October 16, 2023